ctrl K

Watchlist Price Alert

Rapport Therapeutics Inc.... (RAPP)

NASDAQ: RAPP · Real-Time Price · USD

10.90

-0.05 (-0.46%)

At close: Jun 17, 2025, 3:59 PM

Rapport Therapeutics Common Stock Balance Sheet Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	56.8M	70.17M	31.16M
Short-Term Investments	248.47M	77.31M	n/a
Long-Term Investments	n/a	n/a	n/a
Other Long-Term Assets	160K	551K	n/a
Receivables	n/a	n/a	n/a
Inventory	n/a	n/a	n/a
Other Current Assets	4.52M	3.31M	109K
Total Current Assets	309.8M	150.87M	31.27M
Property-Plant & Equipment	4.97M	4M	335K
Goodwill & Intangibles	n/a	n/a	n/a
Total Long-Term Assets	5.13M	4.55M	335K
Total Assets	314.93M	155.42M	31.6M
Account Payables	1.95M	2.5M	1.45M
Deferred Revenue	n/a	n/a	n/a
Short-Term Debt	737K	n/a	n/a
Other Current Liabilities	3.71M	3.22M	n/a
Total Current Liabilities	8.77M	8.8M	1.66M
Long-Term Debt	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	4.2M	10.44M
Total Long-Term Liabilities	739K	5.68M	10.44M
Total Liabilities	9.51M	14.48M	12.1M
Total Debt	1.48M	2.15M	n/a
Common Stock	37K	4K	31K
Retained Earnings	-123.75M	-45.44M	-10.65M
Comprehensive Income	-522K	4K	-31K
Shareholders Equity	305.43M	140.94M	19.5M
Total Investments	248.47M	77.31M	n/a